The success of Sildenafil initially drove a boom for pharma, but recent changes present a murky outlook for investors. Lower-cost competitors are eating into profits, and continued litigation add more difficulty to the https://bronteyvqj984279.blog4youth.com/41702352/sildenafil-and-the-pharmaceutical-industry-a-risky-play